SCHEMBL13345367

SCHEMBL13345367

C=CCCCCOCCN

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 2/20 0.41
LPAR2 Q9HBW0 1/20 0.41
TSHR P16473 2/20 0.37
ALDH1A1 P00352 4/20 0.35
ADORA1 P30542 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
LMNA P02545 1/20 0.32
ABCC4 O15439 1/20 0.32
MAPT P10636 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
TRPA1 O75762 1/20 0.31
SLC2A1 P11166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25113324 0.98 LPAR3 (0.44) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL3786970 0.96 LPAR3 (0.42) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL19619508 0.91 ALDH1A1 (0.35) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL37316 0.87 LPAR3 (0.48) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL22268773 0.87 TSHR (0.37) LPAR3LPAR2TSHRALDH1A1LMNA
SCHEMBL22268682 0.87 LPAR3 (0.37) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL891891 0.85 LPAR3 (0.52) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL2027305 0.85 LPAR3 (0.52) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL2026655 0.85 LPAR3 (0.52) LPAR3LPAR2TSHRALDH1A1ADORA1
SCHEMBL16581541 0.85 LPAR3 (0.46) LPAR3LPAR2TSHRALDH1A1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115895064-A Three-in-one full-plant nourishing antibacterial insole containing ginseng and carex meyeriana latex and manufacturing process of insole 吉林省天佑乌拉草新型材料科技有限公司 2023-04-04 CN disclosed
CN-105198793-B Oxime ester photoinitiators 巴斯夫欧洲公司 2019-08-13 CN disclosed
CN-105531260-B Oxime ester photoinitiator 巴斯夫欧洲公司 2019-05-31 CN disclosed
CN-105358527-B Oxime ester photoinitiator 巴斯夫欧洲公司 2018-09-25 CN disclosed
CN-105175315-B Photo-corrosion-resisting agent composition 巴斯夫欧洲公司 2018-08-28 CN disclosed
CN-107652222-A Oxime ester photoinitiators 巴斯夫欧洲公司 2018-02-02 CN disclosed
CN-104284888-B Oxime ester photoinitiators 巴斯夫欧洲公司 2017-10-27 CN disclosed
CN-106604912-A Oxime sulfonate derivatives 巴斯夫欧洲公司 2017-04-26 CN disclosed
CN-103153952-B The oxime ester derivative of benzo carbazole compound and in photopolymerisable compositions as the purposes of photoinitiator 巴斯夫欧洲公司 2016-07-13 CN disclosed
CN-103443072-B Polymerizable composition comprising oxime sulfonate as thermal curing agent BASF SE (DE) 2016-05-18 CN disclosed
US-20100113504-A1 AMIDE COMPOUNDS AND THEIR USE AS ANTITUMOR AGENTS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-05-06 US disclosed
CN-101687846-A oxime ester photoinitiators BASF SE 2010-03-31 CN disclosed
CN-101687794-A oxime ester photoinitiators BASF SE 2010-03-31 CN disclosed
CN-101679394-A oxime ester photoinitiators BASF SE 2010-03-24 CN disclosed
CN-101636453-A Transparent tinting material, coloured composition and uses thereof BASF SE 2010-01-27 CN disclosed
CN-101384672-A Blue colour filters with enhanced contrast CIBA HOLDING INC (CH) 2009-03-11 CN disclosed
CN-101321727-A Oxime ester photoinitiators CIBA SC HOLDING AG (CH) 2008-12-10 CN disclosed
CN-101023084-A Compositions containing phthalocyanine dyes CIBA SC HOLDING AG (CH) 2007-08-22 CN disclosed
CN-101018829-A Cyanopyridine-based azo dyes HUNTSMAN ADV MAT SWITZERLAND (CH) 2007-08-15 CN disclosed
CN-101014569-A Oxime ester photoinitiators CIBA SC HOLDING AG (CH) 2007-08-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113504-A1 AMIDE COMPOUNDS AND THEIR USE AS ANTITUMOR AGENTS HDAC3, HCCS, CCNH LPAR3 651/4885LPAR2 3102/4885TSHR 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.